Skip to main content
TipRanks
Go Ultimate75% OFF

Beijing Biostar Pharmaceuticals Co., Ltd. Class H (2563) Income Statement

0 Followers

Beijing Biostar Pharmaceuticals Co., Ltd. Class H Income Statement

Last quarter (Q2 2026), Beijing Biostar Pharmaceuticals Co., Ltd. Class H's total revenue was HK$21.16M, a decrease of 3.51% from the same quarter last year. In Q2, Beijing Biostar Pharmaceuticals Co., Ltd. Class H's net income was HK$-15.36M. See Beijing Biostar Pharmaceuticals Co., Ltd. Class H’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Jun 25Dec 23Dec 22Dec 21
HK$ 37.12MHK$ 77.92MHK$ 73.75MHK$ 37.38MHK$ 106.74M
HK$ 33.65MHK$ 66.75MHK$ 51.83MHK$ 27.20MHK$ 100.48M
HK$ 183.68MHK$ 218.02MHK$ 293.09MHK$ 255.14MHK$ 511.93M
Depreciation and AmortizationHK$ 11.62MHK$ 10.54MHK$ 11.76MHK$ 11.96MHK$ 10.66M
HK$ -139.77MHK$ -173.84MHK$ -198.08MHK$ -170.77MHK$ -430.65M
HK$ -151.39MHK$ -184.38MHK$ -241.26MHK$ -227.94MHK$ -411.45M
HK$ 8.84MHK$ 28.49MHK$ 31.36MHK$ 45.13MHK$ -6.34M
HK$ -142.54MHK$ -155.89MHK$ -209.90MHK$ -182.81MHK$ -417.79M
HK$ -142.54MHK$ -155.89MHK$ -209.90MHK$ -182.81MHK$ -417.79M
Per Share Metrics
Basic EPSHK$ -0.39HK$ -0.43HK$ -0.58HK$ -0.50HK$ -1.19
Diluted EPSHK$ -0.39HK$ -0.43HK$ -0.58HK$ -0.50HK$ -1.19
Weighted Average Shares Outstanding365.10M364.59M364.59M364.59M350.00M
Weighted Average Shares Outstanding (Diluted)365.10M364.59M364.59M364.59M350.00M

Currency in HKD

Beijing Biostar Pharmaceuticals Co., Ltd. Class H Earnings and Revenue History

-500M-250M0250M-600 %-450 %-300 %-150 %EarningsProfit Margin2019202020212022202320242025RevenueEarningsProfit Margin